US Patent 8293794 Methods and compositions for the treatment of CNS-related conditions

Patent 8293794 was granted and assigned to Adamas Pharmaceuticals, Inc. on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82937940

Patent Inventor Names

Gregory T. Went0

Laurence R. Meyerson0

Timothy J. Fultz0

Date of Patent

October 23, 2012

Patent Application Number

127537690

Date Filed

April 2, 2010

Patent Citations Received

‌

US Patent 11903908 Methods of administering amantadine

Patent Primary Examiner

‌

Sreeni Padmanabhan

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8293794 Methods and compositions for the treatment of CNS-related conditions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.